Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
about
Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated TET1 expression.Screening and identification of critical transcription factors involved in the protection of cardiomyocytes against hydrogen peroxide-induced damage by Yixin-shu.High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.
P2860
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low-dose Actinomycin-D treatme ...... 3 in RELA-positive ependymoma.
@en
Low-dose Actinomycin-D treatme ...... 3 in RELA-positive ependymoma.
@nl
type
label
Low-dose Actinomycin-D treatme ...... 3 in RELA-positive ependymoma.
@en
Low-dose Actinomycin-D treatme ...... 3 in RELA-positive ependymoma.
@nl
prefLabel
Low-dose Actinomycin-D treatme ...... 3 in RELA-positive ependymoma.
@en
Low-dose Actinomycin-D treatme ...... 3 in RELA-positive ependymoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Low-dose Actinomycin-D treatme ...... 3 in RELA-positive ependymoma.
@en
P2093
Andrea Wittmann
Andreas E Kulozik
Andrey Korshunov
David T W Jones
Hendrik Witt
Kristian W Pajtler
Magdalena Schlotter
Marcel Kool
Sebastian Bender
P2860
P304
61860-61873
P356
10.18632/ONCOTARGET.11452
P407
P577
2016-08-20T00:00:00Z